research Understanding the Impact of Reperfusion in the Development of a Safe Compression Therapy
This study developed a modified ischemia/reperfusion protocol to test the safety and efficacy of intermittent compression therapy without causing soft-tissue injuries. Using C57BL/6 male mice, the researchers applied repeated compression, which initially stunted hair growth but allowed regrowth within 18 days. The pressure increased epidermal thickness and CD31+ cell numbers while reducing adipocyte volume and CD34 volume fraction, without affecting stem cell populations or increasing DNA damage markers. The model effectively allowed analysis of uninjured skin post-compression, demonstrating limited negative effects on tissue.